azelastine has been researched along with mocetinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmidt, J; Szelenyi, I; Werner, U | 1 |
| Bagnasco, M; Bertolini, C; Canonica, GW; Ciprandi, G; Grögen, J; Mela, GS; Passalacqua, G; Pronzato, C; Ricca, V; Varese, P | 1 |
1 trial(s) available for azelastine and mocetinostat
| Article | Year |
|---|---|
Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity.
Topics: Administration, Topical; Adolescent; Adult; Allergens; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Double-Blind Method; Eosinophil Granule Proteins; Eosinophils; Epithelium; Histamine H1 Antagonists; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Middle Aged; Nasal Mucosa; Nasal Provocation Tests; Peroxidase; Phthalazines; Ribonucleases | 1996 |
1 other study(ies) available for azelastine and mocetinostat
| Article | Year |
|---|---|
Influence of azelastine on IL-1 beta generation in vitro and IL-1 beta-induced effect in vivo.
Topics: Adult; Animals; Biomarkers; Histamine H1 Antagonists; Humans; In Vitro Techniques; Inflammation; Interleukin-1; Male; Mice; Neutrophils; Peroxidase; Phthalazines; Recombinant Proteins | 1991 |